A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
Clinical trial NCT01251120 · TERMINATED
Trial details
- NCT number
- NCT01251120
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.